Continuous subcutaneous insulin infusion reduces neonatal risk in pregnant women with type 1 diabetes mellitus.
Urszula MantajKatarzyna Wroblewska-SeniukKatarzyna OzegowskaAgnieszka ZawiejskaAgnieszka ZawiejskaDanuta OlejniczakPawel GutajPublished in: Ginekologia polska (2020)
The use of CSII in the treatment of pregnant women with type 1 diabetes was associated with reduced number of neonatal complications presented as neonatal composite outcome but had no influence on maternal outcome.